Trending Stories : Business

Eli Lilly Declares War on Pharmacy Middlemen, Sparking Drug Price Shakeup

Eli Lilly is launching a direct assault on pharmacy benefit managers (PBMs), the powerful middlemen who control drug pricing and access in the U.S. The pharmaceutical giant plans to bypass PBMs by offering its weight-loss and diabetes medications directly to patients and employers, aiming to cut out fees that inflate costs. This move challenges the dominance of PBM giants like CVS Caremark, Express Scripts, and OptumRx, which handle benefits for millions of Americans. For families managing chronic conditions like obesity and diabetes, this could mean lower out-of-pocket expenses and faster access to treatments. We see this as a pivotal shift in healthcare economics, potentially pressuring other drugmakers to follow suit and reshaping how Americans pay for essential medicines amid rising obesity rates.